Home

  • Order to parcel locker

    Order to parcel locker

  • easy pay

    easy pay
  • Reduced price
Patient Management with Stable Ischemic Heart Disease, An Issue of Medical Clinics of North America

Patient Management with Stable Ischemic Heart Disease, An Issue of Medical Clinics of North America

9780443293689
PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 14 DAYS
423.31 zł
359.81 zł Save 63.50 zł Tax included
Lowest price within 30 days before promotion: 359.81 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DHL, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
In this issue of Medical Clinics of North America, guest editors Drs. Alexander Fanaroff and John W. Hirschfeld, Jr., bring their considerable expertise to the topic of Patient Management with Stable Ischemic Heart Disease. Top experts provide insights into newer diagnostic modalities for patients presenting with symptoms of stable ischemic heart disease, review the pillars of medical management as well as emerging cardiometabolic therapies, provide updates on the role of revascularization, and reveal gender, racial, ethnic, and socioeconomic disparities in the presentation and management of stable ischemic heart disease.
Product Details
Elsevier
100413
9780443293689
9780443293689

Data sheet

Publication date
2024
Issue number
1
Cover
hard cover
Pages count
240
Dimensions (mm)
152 x 229
Weight (g)
450
  • The Pathophysiologic Basis of Managing Chronic Atherosclerotic Cardiovascular Disease
    Diagnosing Coronary Artery Disease in the Patient Presenting with Stable Ischemic Heart Disease: The Role of Anatomic versus Functional Testing
    Optimal Medical Therapy for Stable Ischemic Heart Disease in 2024: Focus on Blood Pressure and Lipids
    Optimal Medical Therapy for Stable Ischemic Heart Disease: Focus on Anti-anginal Therapy
    A New Age for Secondary Prevention: Optimal Medical Therapy for Stable Ischemic Heart Disease Among Patients with Diabetes and/or Obesity
    Optimal Medical Therapy for Chronic Coronary Disease in 2024: Focus on Antithrombotic Therapy
    Optimal Medical Therapy for Stable Ischemic Heart Disease in 2024: Focus on Exercise and Cardiac Rehabilitation
    When to Consider Coronary Revascularization for Stable Coronary Artery Disease
    Antiplatelet Therapy for Patients Who Have Undergone Revascularization Within the Past Year: Which Agents and for How Long?
    Medical Decision-Making and Revascularization in Ischemic Cardiomyopathy
    Ischemic Heart Disease in Women
    Chronic Coronary Disease in Older Adults
    Racial and Ethnic Disparities in the Management of Chronic Coronary Disease
Comments (0)
Viewed products

  • Frequently purchased together

    No products available